In this latest episode, we sit down with Jackie DeAngelis, a seasoned journalist and host on Fox Business Network, to discuss her personal journey with breast cancer. Diagnosed four years ago, Jackie shares her emotional and physical experience navigating treatment, including her decision to undergo a double mastectomy. She emphasizes the importance of early screening, understanding family history, and managing modifiable risk factors to improve outcomes. Jackie highlights key links between lifestyle choices and breast cancer risk, such as maintaining a healthy weight, limiting alcohol consumption, and avoiding tobacco. As the host of Fox Business, she brings her insights into the significance of awareness and proactive health measures. Tune in for an inspiring conversation on resilience, prevention, and the importance of being informed about breast cancer risks.

1. American Cancer Society (ACS) - Breast Cancer Screening & Risk Factors
2. https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection.html
3. Centers for Disease Control and Prevention (CDC) - Breast Cancer: Risks and Screening
4. https://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
5. National Cancer Institute (NCI) - Breast Cancer Prevention and Risk Factors
6. https://www.cancer.gov/types/breast/patient/breast-prevention-pdq
7. World Health Organization (WHO) - Breast Cancer Screening
8. https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
9. Mayo Clinic - Breast Cancer risk factors and screening tests
10. https://www.mayoclinic.org/diseases-conditions/breast-cancer/in-depth/breast-cancer/art-20048268

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Your Health First: Advancements in Robotic Surgery & Live Liver Donation at Houston Methodist

Join Dr. Joe Galati on this episode of "Your Health First" as he speaks with leading surgeons from Houston Methodist Hospital, Dr. Simon and Dr. Yee Lee Cheah. Broadcasting live from 740 KTRH in Houston and worldwide on the iHeartRadio app every Sunday at 7:00 PM Central, this insightful discussion delves into the groundbreaking work being done in robotic surgery and the current status of the live donor liver transplant program at Houston Methodist.

Dr. Simon and Dr. Cheah share their expertise on the numerous benefits of robotic surgery, highlighting the significant advantages for patients and the remarkable advancements in technology over the past 5-10 years. They also provide a comprehensive overview of the meticulous patient selection process for live liver donors and detail the structured program at Houston Methodist Hospital.

Don't miss this opportunity to learn about the cutting-edge surgical techniques and life-saving transplant procedures making a difference in patient care.

For more information:

• Dr. Simon & Dr. Cheah: www.houstonmethodist.org
• Dr. Joe Galati: www.drjoegalati.com

Dr. Simon:

Dr. Simon is a highly accomplished surgeon with a specialization in abdominal transplantation and hepatobiliary surgery. She earned her medical degree with honors from University College Cork Faculty of Medicine in Ireland in 2002 and completed her general surgery residency at Brown University Program, Rhode Island Hospital. Dr. Simon further honed her expertise with a research fellowship in Diagnostic Imaging at Brown University and an ASTS-certified fellowship in Abdominal Transplantation and Hepatobiliary Surgery at Lahey Hospital & Medical Center. Her clinical interests are extensive, encompassing both benign and malignant tumors of the liver, bile duct, and pancreas, including hepatocellular carcinoma and Klatskin tumors. She is also deeply involved in kidney transplantation, living and deceased donor liver transplantation, pancreatic carcinoma, robotic surgery, and surgery for portal hypertension. Dr. Simon is board-certified in general surgery by the American Board of Surgery and is a Fellow of the American College of Surgeons (FACS).

Dr. Yee Lee Cheah:

Dr. Yee Lee Cheah is a distinguished surgeon who joined the J.C. Walter Jr. Transplant Center at Houston Methodist Hospital in 2022. She graduated with honors from the Royal College of Surgeons in Ireland in 2000 and completed her General Surgery Residency at the Brown University Program. Dr. Cheah further specialized with an ASTS-accredited fellowship in Transplantation & Hepatobiliary Surgery at the Lahey Clinic. Prior to Houston Methodist, she played a pivotal role at the Asian American Liver Centre at Gleneagles Hospital, the largest adult living donor liver transplantation (LDLT) center in Southeast Asia, before returning to LHMC to develop their LDLT and robotic surgery programs. Her expertise lies in living donor liver transplantation, robotic transplantation, HPB surgery for benign and malignant disorders, and nutrition therapy for surgical patients. Dr. Cheah's main research interests are centered on living donor safety and robotic surgery. She has held faculty positions at Brown University and Tufts University and served as an Adjunct Assistant Professor at the National University of Singapore.

Hosted on Acast. See acast.com/privacy for more information.

Welcome to this week’s episode of our podcast, where we delve into an important and often discussed topic in men's health—prostate cancer. Today, we’ll explore the latest insights into how prostate cancer is diagnosed and treated, providing valuable information for both patients and healthcare providers. A key focus will be on the role of PSA testing, its benefits, limitations, and how it fits into the broader screening and diagnostic process.

Joining us as our expert guest is Dr. Brian Miles, a renowned specialist in urology and prostate health. With his expertise, we aim to shed light on current advancements, best practices, and emerging trends in prostate cancer management. Whether you’ve just been diagnosed, are due for screening, or simply want to stay informed, this episode offers essential knowledge to help you navigate this important health topic. Stay tuned!

Where to find Dr. Joe Galati and his team:

Dr. Galati's newsletter sign-up

Medical Practice: Liver Specialists of Texas

Dr. Galati's Book Site: Eating Yourself Sick

Facebook: Dr. Joe Galati

Dr. Galati's YouTube Channel

Please send feedback and suggestion. You can message me here.

Hosted on Acast. See acast.com/privacy for more information.

On this week’s broadcast of YOUR HEALTH FIRST, we discussed several important health news items, including the recent diagnosis of prostate cancer in President Biden. 

While we all offer him our best wishes and support, the announcement has sparked considerable discussion about how this may have unfolded.

Over the past 15 years, strategies for prostate cancer screening have evolved significantly. The use of the blood test known as prostate-specific antigen (PSA) has been at the center of research and clinical debate. In earlier years, even mildly elevated PSA levels often led to prostate biopsies. However, growing concerns about overdiagnosis and overtreatment have led to more conservative approaches, with many physicians opting for careful monitoring rather than immediate invasive procedures.

It is unclear exactly how this approach factored into President Biden’s case. However, in speaking with several leading prostate cancer experts in the Houston area, there was broad agreement: it’s likely that his PSA levels had been elevated over time, but the decision was made to monitor the situation closely rather than proceed with a biopsy right away.

Whether or not political considerations influenced the timing or manner of this diagnosis is something that will likely be debated in the weeks, months, and years to come.

Where to find Dr. Joe Galati and his team:

Dr. Galati's newsletter sign-up

Medical Practice: Liver Specialists of Texas

Dr. Galati's Book Site: Eating Yourself Sick

Facebook: Dr. Joe Galati

Dr. Galati's YouTube Channel

Please send feedback and suggestion. You can message me here.

Hosted on Acast. See acast.com/privacy for more information.

In this LATEST PODCAST episode, we dive into the concept of "Medical Whack-a-Mole," a term I coined to describe the all-too-frequent scenario in healthcare where physicians treat individual problems by passing patients from one specialist to another. This process often leads to patients being prescribed a staggering number of medications—sometimes even as many as 28, as seen in a recent case involving a patient managing five chronic conditions under six different doctors.

Join me as I unpack this concerning phenomenon and share personal insights from my experience. We'll explore the implications of overmedication and how it detrimentally impacts patient health and wellness, undermining the very goal of making America healthy again. Together, we’ll discuss empowering patients to become better consumers of their healthcare, raising their health IQ, and advocating for themselves. Discover why it's essential to disrupt the whack-a-mole cycle of treatment and take control of chronic disease management, because the stakes couldn't be higher. Tune in for a crucial conversation about reshaping the future of healthcare for the betterment of all.

Where to find Dr. Joe Galati and his team:

Dr. Galati's newsletter sign-up

Medical Practice: Liver Specialists of Texas

Telephone: 713-794-0700

Dr. Galati's Book Site: Eating Yourself Sick

Facebook: Dr. Joe Galati

Dr. Galati's YouTube Channel

Please send feedback and suggestion. You can message me here.

Hosted on Acast. See acast.com/privacy for more information.

The New York Times article from April 23, 2025, discusses a study identifying 17 overlapping factors that influence the risk of stroke, dementia, and late-life depression. The research emphasizes that lifestyle changes can simultaneously lower the risk of all three conditions. Experts highlight that these diseases often coexist due to shared underlying damage to small blood vessels in the brain, with risk factors like high blood pressure and diabetes contributing to this damage.

The study identifies six factors that protect against brain diseases. These include low to moderate alcohol intake, consistent cognitive activity through mentally stimulating tasks, a diet rich in vegetables, fruits, dairy, fish, and nuts, moderate to high levels of physical activity, a strong sense of purpose in life, and maintaining a large social network. Conversely, the article outlines 13 health characteristics and habits that increase the risk of developing these conditions, such as high blood pressure, high body mass index, high blood sugar, high total cholesterol, depressive symptoms, a diet high in red meat, sugar-sweetened beverages, sweets and sodium, hearing loss, kidney disease, pain (particularly when it interferes with activity), sleep disturbances, a smoking history, loneliness or isolation, and general stress or stressful life events.

The article emphasizes that reducing high blood pressure is particularly beneficial, as it is the greatest individual risk factor for developing stroke, dementia, and depression. It also suggests incorporating physical and mental exercises into one's routine, ideally with friends to add a social element. The best time to start making these lifestyle changes is in middle age to prevent early disease development. Ultimately, the article encourages readers to view these factors as a "menu of options," tackling them step-by-step to take better care of their brain health.

#BrainHealth #DementiaPrevention #StrokePrevention #DepressionAwareness #HealthyLifestyle

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we take a deep dive into the global epidemic of fatty liver disease, also known as metabolic dysfunction associated steatotic liver disease (MASLD). Dr. Noureddin sheds light on alarming statistics: nearly one in four adults globally suffers from this condition, which can lead to serious liver complications. We discuss how fatty liver disease often accompanies other metabolic disorders, such as type 2 diabetes, hypertension, and elevated cholesterol levels, creating a complex web of health challenges for affected individuals.

The conversation touches upon the epidemiology of fatty liver disease, exploring how socioeconomic factors and lifestyle choices contribute to its rapid proliferation. Dr. Noureddin explains the disease's natural history, detailing how it can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), cirrhosis, and even liver cancer. We discuss the critical importance of early diagnosis and risk assessment, as many individuals remain asymptomatic until the disease reaches advanced stages.

Furthermore, our discussion highlights the increasing need for liver transplants due to the progression of fatty liver disease complications. Dr. Noureddin shares breakthroughs in research and potential new therapies on the horizon, including pharmacologic treatments aimed at reversing liver damage and improving metabolic health.

For those seeking to learn more or get involved in the discussion about fatty liver disease, feel free to reach out to me at DrJoeGalati.com.

#FattyLiverDisease 

#MetabolicHealth 

#LiverResearch 

#Diabetes 

#Obesity 

Join us for this crucial conversation as we aim to raise awareness and provide insights into the complexities of fatty liver disease and its growing impact on global health!

Hosted on Acast. See acast.com/privacy for more information.

In this latest podcast episode, we delve into the groundbreaking research of Jonathan Stine, MD, a renowned liver specialist and faculty member at Penn State, who is making significant strides in the field of fatty liver disease research. Originally aired as part of a radio segment on YOUR HEALTH FIRST, this engaging podcast episode features Dr. Stine's compelling insights and findings on the impactful role of exercise in reversing the damage associated with fatty liver disease.

Fatty liver disease, a condition that affects millions worldwide, poses a substantial threat to public health, often leading to more severe liver problems and related health issues if left unmanaged. Dr. Stine and his dedicated team have been at the forefront of research aiming to combat this growing epidemic. Their work highlights how intensive exercise programs serve not only as a preventive measure but also as a potential therapeutic strategy for patients already suffering from fatty liver.

During the interview, Dr. Stine discusses the promising outcomes of his team's studies, which indicate that rigorous exercise can significantly reduce liver fat, improve liver function, and potentially halt or even reverse the progression of liver damage. This discovery offers hope to patients and healthcare practitioners alike, introducing a non-pharmacological approach that empowers individuals in managing their health. 

Listeners will gain valuable insights into how lifestyle modifications, particularly through structured exercise regimens, can transform health outcomes. Dr. Stine's research opens new pathways for treatment and highlights the crucial role of an active lifestyle in maintaining liver health. Tune in to learn more about these remarkable findings and how they are paving the way for innovative treatment options in the fight against fatty liver disease.

Where to find Dr. Joe Galati and his team:

Dr. Galati's newsletter sign-up

Medical Practice: Liver Specialists of Texas

Dr. Galati's Book Site: Eating Yourself Sick

Facebook: Dr. Joe Galati

Dr. Galati's YouTube Channel

Please send feedback and suggestion. You can message me here.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.